Amedeo Smart

Free Medical Literature Service

 

Amedeo

Diabetes
  Free Subscription

Articles published in
Am J Manag Care
    December 2025
  1. SHENOY DA, Cummins L, Kaplan S, Zullig LL, et al
    Interventions addressing cost-related medication nonadherence in diabetes: a scoping review.
    Am J Manag Care. 2025;31.
    >> Share

  2. PANGRACE M, Albright J, Basta S, Bratcher T, et al
    Exploratory study of selected stakeholder insights into continuous glucose monitoring in T2D with risk-sharing agreements.
    Am J Manag Care. 2025;31.
    >> Share

  3. SHOAIB N, Azhar N, Shoaib M
    GLP-1 receptor agonists: trend, necessity, or blessing?
    Am J Manag Care. 2025;31.
    >> Share

  4. PATEL BV, Wang SM, Messer LH, Pinsker JE, et al
    HEDIS glycemic goal achieved using control-IQ Technology.
    Am J Manag Care. 2025;31:e357-e363.
    >> Share

    November 2025
  5. BORRELLI EP, Saad P, Barnes NE, Beer I, et al
    Relationship between medication adherence and other Medicare star rating measures.
    Am J Manag Care. 2025;31:688-692.
    >> Share

    October 2025
  6. TURK MT, Ritchie ND, Norton B, Gallucci A, et al
    Opportunities and obstacles associated with the Medicare Diabetes Prevention Program.
    Am J Manag Care. 2025;31:578-582.
    >> Share

    September 2025
  7. KAUR M, Ives B, Mijanovich T, Singh P, et al
    Workforce innovation reduces Medicaid costs in chronic care.
    Am J Manag Care. 2025;31.
    >> Share

  8. LIU G, Jarema M, Mo M, Stievater T, et al
    Navigating compounded semaglutide: what health care providers need to know.
    Am J Manag Care. 2025;31:480-484.
    >> Share

    August 2025
  9. UKHANOVA M, Wozny JS, Truong CN, Ghosh L, et al
    Trends in glucagon-like peptide 1 receptor agonist prescribing patterns.
    Am J Manag Care. 2025;31:e228-e234.
    >> Share

  10. TREMBLAY ES, Argetsinger S, Zhang F, Ross-Degnan D, et al
    Trends in insulin out-of-pocket costs and use disparities, 2008-2021.
    Am J Manag Care. 2025;31:408-412.
    >> Share

    April 2025
  11. MARRERO DG, Parkin CG, Aleppo G, Hirsch IB, et al
    The role of advanced technologies in improving diabetes outcomes.
    Am J Manag Care. 2025;31:e102-e112.
    >> Share

  12. KOMMAREDDI M, Wherry K
    Cost-effectiveness of the MiniMed 780G system for type 1 diabetes.
    Am J Manag Care. 2025;31:e79-e86.
    >> Share

  13. NEMLEKAR PM, Hannah KL, Green CR, Grace T, et al
    Combined effect of continuous glucose monitoring and semaglutide: analysis of administrative claims.
    Am J Manag Care. 2025;31:183-188.
    >> Share

    March 2025
  14. ABRAHAM JM, Ambroz T, Chacon M, Kidney RSM, et al
    Real-world digitally based diabetes management program implementation by a large employer.
    Am J Manag Care. 2025;31:e62-e68.
    >> Share

    January 2025
  15. VILLAVERDE Z, Hinman RH 2nd, Grimes RM
    Physiologic insulin resensitization lowers cost in patients with diabetes and kidney disease.
    Am J Manag Care. 2025;31:e11-e14.
    >> Share

  16. ERNST K, Thompson AN, Bensami A, Choe HM, et al
    Collaboration to transition members to preferred formulary dipeptidyl-peptidase-4 inhibitor.
    Am J Manag Care. 2025;31:20-24.
    >> Share

    December 2024
  17. NEELAND IJ, Rajagopalan S
    A team-based approach to type 2 diabetes and cardiovascular care.
    Am J Manag Care. 2024;30.
    >> Share

  18. HANDELSMAN Y
    Diabetes, cardiorenal, and metabolic multispecialty practice recommendations and early intensive management of cardio-renal-metabolic disease.
    Am J Manag Care. 2024;30.
    >> Share

  19. FERDINAND KC
    An overview of cardiovascular-kidney-metabolic syndrome.
    Am J Manag Care. 2024;30.
    >> Share

    September 2024
  20. BETTS KA, Oberprieler NG, Wu A, James G, et al
    Antihyperglycemic treatment patterns for chronic kidney disease and type 2 diabetes.
    Am J Manag Care. 2024;30:405-412.
    >> Share

    August 2024
  21. HUANG HC, Touchette DR, Tadrous M, Schumock GT, et al
    Adherence patterns 1 year after initiation of SGLT2 inhibitors: results of a national cohort study.
    Am J Manag Care. 2024;30:e226-e232.
    >> Share

    May 2024
  22. POONAWALLA IB, Chung L, Shetler S, Pearce H, et al
    Medication adherence star ratings measures, health care resource utilization, and cost.
    Am J Manag Care. 2024;30:210-217.
    >> Share

  23. NOBLE M, Chen F, Linke S, Dall TM, et al
    Modeling the economic value of cardiometabolic virtual-first care programs.
    Am J Manag Care. 2024;30.
    >> Share

    April 2024
  24. CHOE JH, Xuan S, Goldenberg A, Matian J, et al
    Medication persistence and its impact on type 2 diabetes.
    Am J Manag Care. 2024;30:e124-e134.
    >> Share

  25. KUMAR A, Dowd-Green C, Green R, Stewart R, et al
    Institutional practices for charitable medication access for uninsured patients.
    Am J Manag Care. 2024;30:e135-e139.
    >> Share

    March 2024
  26. HOFFMAN AF, Roberson CL, Cohen P, Jackson VL, et al
    Improving glycemic control in diabetes through virtual interdisciplinary rounds.
    Am J Manag Care. 2024;30:e78-e84.
    >> Share

  27. QUACH J, Midlam C, Sell C, Levin-Scherz J, et al
    Out-of-pocket costs for diabetes medications in employer-sponsored health insurance plans.
    Am J Manag Care. 2024;30:107-108.
    >> Share

  28. LAMONICA LC, Ren J, Jain N, Goldberg ES, et al
    At-home hemoglobin A1c testing during COVID-19 improved glycemic control.
    Am J Manag Care. 2024;30:e73-e77.
    >> Share

  29. LO JC, Chandra M, Yang W, Thompson N, et al
    Challenges of fracture risk assessment in Asian and Black women.
    Am J Manag Care. 2024;30:140-144.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016